Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management

BACKGROUND: Despite major advances in the treatment of diabetic nephropathy (DN) in recent years, it remains the most common cause of end-stage renal disease. An early diagnosis and therapy may slow down the DN progression. Numerous potential biomarkers are currently being researched. Circulating le...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Lei, Chen, Yu, Shi, Shaoqing, Wen, Heling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785577/
https://www.ncbi.nlm.nih.gov/pubmed/35073973
http://dx.doi.org/10.1186/s13287-021-02696-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785577/
https://www.ncbi.nlm.nih.gov/pubmed/35073973
http://dx.doi.org/10.1186/s13287-021-02696-w

Ejemplares similares